Thu, Feb 17, 2022 11:00 AM – 12:00 PM EST Register >> Exacerbated by the pandemic, Mental Health disorder prevalence continues to rise. The growing unmet need is driving a renewed interest in research and development programs. Yet, the complexities of these neurological conditions continue to present challenges. Deep clinical data can offer insights into[…]
Tue, Jan 25, 2022 12:30 PM – 1:30 PM EST Presenter: Rich Gliklich, CEO, OM1 Register >> Real-World Data (RWD) and Artificial Intelligence (AI) applications are rapidly growing in importance in R&D for Chronic and Immune-mediated Diseases. Join us as we explore: Data Networks The ‘Unstructured’ Medical Record Hybrid Data Collection Data Linkage Artificial Intelligence[…]
December 20, 2021 – Orphanet Journal of Rare Diseases Read the Full Article >> Background Fabry disease (FD) is a rare genetic disorder characterized by glycosphingolipid accumulation and progressive damage across multiple organ systems. Due to its heterogeneous presentation, the condition is likely significantly underdiagnosed. Several approaches, including provider education efforts and newborn screening, have[…]
Wed, Nov 17, 2021 11:00 AM – 12:00 PM EST Presenter: Dr. Joseph Zabinski, Senior Director of Data Solutions, OM1 Register >> Artificial Intelligence (AI) technology is increasingly being used for accelerating and optimizing clinical development. Yet, understanding useful implementation and its real-world impact remain challenging. Join this webinar to explore: Real-world applications for AI[…]
SEPTEMBER 15, 2021 By Joseph Zabinski, PhD, Senior Director of AI & Precision Medicine, OM1 As innovation in devices and diagnostics accelerates, research approaches and outcomes programs also need to advance to support these developments with high-quality evidence. At the same time, demonstrating the effectiveness of a device can be challenging because outcomes depend highly[…]
